DIA 48th Annual Meeting
Click here to go to the previous page
Leaping the Valley of Death: Keys to Successfully Going from the Lab to the Clinic for Pharmaceutical Products
Track
:
Track 02: Project/Portfolio Management and Strategic Planning
Program Code:
244
Date:
Tuesday, June 26, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Michael Swit, Duane Morris, LLP, United States
PRESENTER
(S):
Gerald Yakatan, IriSys, Inc., United States
Nayan Nanavati, Jubilant Clinsys, United States
Heidi Kraus Politis, Abon Pharmaceuticals, LLC, United States
Description
Going from the lab to the clinic is the first huge leap in drug development. This session will explore how to ensure that the jump over the "valley of death" is smooth and avoids the sponsor falling into an abyss of bad decisions and poor results.
Learning Objectives:
Discuss the crucial decisions to jump from lab to clinic and how those decisions can speed or derail drug development
Identify strategies to analyze unexpected challenges and minimize their impact on drug development
State how to use internal and external resources to succeed.
Learning Objectives:
Discuss the crucial decisions to jump from lab to clinic and how those decisions can speed or derail drug development
Identify strategies to analyze unexpected challenges and minimize their impact on drug development
State how to use internal and external resources to succeed.
This session is a part of:
Handout Online
